ClinConnect ClinConnect Logo
Search / Trial NCT03481010

Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology

Launched by OTTAWA HOSPITAL RESEARCH INSTITUTE · Mar 21, 2018

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying whether performing a hip arthroscopy, which is a minimally invasive surgery to look inside the hip joint, at the same time as a periacetabular osteotomy (PAO) can improve recovery and outcomes for patients with hip dysplasia. The PAO is a surgery that helps realign the hip joint to relieve pain and improve function. Participants in this study will be randomly assigned to either have only the PAO or to have both surgeries at the same time.

To be eligible for this trial, participants must be between 16 and 50 years old and have a specific type of hip problem called acetabular dysplasia. They also need to be able to understand the study and give their consent. Unfortunately, those who have had previous hip surgeries, certain medical disorders, or specific types of arthritis cannot participate. If you join the study, you will receive careful monitoring and follow-up to assess your recovery and overall outcomes after the surgeries. This research aims to provide clearer answers on the best approach to treating hip dysplasia.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Skeletally mature patient undergoing Bernese periacetabular osteotomy for symptomatic acetabular dysplasia/hip instability
  • Pre-Operative MRI at 3T and/or gadolinium MR arthrogram
  • Age, 16-50 years old
  • Patient capable of giving informed consent
  • Exclusion Criteria:
  • Prior hip/pelvis surgery of any kind on the surgical side
  • Prior hip arthroplasty surgery on either side
  • Radiographic evidence of arthritis (i.e. Tönnis grade =2)
  • Known connective tissue disorder (e.g. Ehlers-Danlos Syndrome, etc.)
  • Known neuromuscular disorder (e.g. Cerebral Palsy, Spina bifida, etc.)
  • Known skeletal dysplasia (e.g. Achondroplasia, Multiple Epiphyseal Dysplasia, etc.)
  • Cognitive impairment that prevents accurate completion of patient-reported outcome questionnaires.
  • Patient unable/unwilling to complete all required follow-up visits
  • Concurrent proximal femoral osteotomy and/or surgical hip dislocation

About Ottawa Hospital Research Institute

The Ottawa Hospital Research Institute (OHRI) is a leading academic research institute dedicated to advancing health and healthcare through innovative research and evidence-based practices. Affiliated with The Ottawa Hospital and the University of Ottawa, OHRI fosters a collaborative environment that brings together clinicians, scientists, and trainees to conduct groundbreaking clinical trials and translational research. With a focus on improving patient outcomes, OHRI specializes in a wide range of fields, including cancer, cardiovascular health, and regenerative medicine. The institute is committed to ethical research practices and the dissemination of knowledge to enhance public health and inform healthcare policy.

Locations

Chicago, Illinois, United States

New York, New York, United States

Ottawa, Ontario, Canada

Royal Oak, Michigan, United States

Ottawa, Ontario, Canada

Québec, , Canada

Saint Louis, Missouri, United States

Patients applied

0 patients applied

Trial Officials

Geoffrey Wilkin, MD

Principal Investigator

The Ottawa Hospital Research Institute

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials